Inui Y, Giannoni F, Funahashi T, Davidson N O
Department of Medicine, University of Chicago, IL 60637.
J Lipid Res. 1994 Aug;35(8):1477-89.
Apolipoprotein B (apoB) mRNA editing is a post-transcriptional cytidine deamination involving several protein factor(s), one of which has recently been cloned. We have examined the effects of alterations in cellular cholesterol flux in the rat liver and small intestine as a means of dissecting the physiologic mechanisms regulating apoB mRNA editing, both in vivo and in isolated S-100 extracts. Hepatic cholesteryl ester accumulation was produced by feeding rats a high cholesterol diet, alone, or in combination with either ethinyl estradiol treatment, or after induction of hypothyroidism. Endogenous hepatic apoB mRNA editing decreased in parallel with the increase in cellular cholesteryl ester content (r = -0.948, P < 0.001). None of these conditions altered endogenous intestinal apoB mRNA editing. Hepatic S-100 extracts demonstrated decreased in vitro apoB RNA editing activity, in parallel with the changes observed in vivo. By contrast, the activity of intestinal S-100 extracts demonstrated a paradoxical increase in hypothyroid rats and a similar, paradoxical decrease in hyperthyroid rats, when compared to controls. Hepatic REPR mRNA, quantitated by RNase protection assay, showed a 25-50% decrease in cholesterol-fed rats. The editing activity of hepatic S-100 extracts prepared from cholesterol-fed, hypothyroid rats was restored to control levels with REPR supplementation but not with chicken intestinal S-100 extracts, suggesting that changes in REPR, but not complementation activity, may play a critical role in the regulation of apoB mRNA editing in rat liver. By contrast, the editing activity of intestinal S-100 extracts prepared from hyperthyroid animals was unaltered by supplementation with REPR, but was restored to control levels after the addition of chicken intestinal S-100 extracts. Taken together, the data suggest that tissue-specific factors regulate apoB mRNA editing in the rat and that the complex interplay of REPR and complementation factor(s) may be modulated in response to alterations in cholesterol flux, in vivo.
载脂蛋白B(apoB)mRNA编辑是一种涉及多种蛋白质因子的转录后胞嘧啶脱氨基作用,其中一种蛋白质因子最近已被克隆。我们研究了大鼠肝脏和小肠中细胞胆固醇通量改变的影响,以此作为剖析体内和分离的S-100提取物中调节apoB mRNA编辑的生理机制的一种手段。通过给大鼠喂食高胆固醇饮食,单独喂食,或与乙炔雌二醇联合治疗,或在诱导甲状腺功能减退后,可导致肝脏胆固醇酯积累。肝脏内源性apoB mRNA编辑与细胞胆固醇酯含量的增加呈平行下降(r = -0.948,P < 0.001)。这些情况均未改变内源性肠道apoB mRNA编辑。肝脏S-100提取物显示体外apoB RNA编辑活性降低,与体内观察到的变化一致。相比之下,与对照组相比,甲状腺功能减退大鼠的肠道S-100提取物活性出现反常增加,而甲状腺功能亢进大鼠则出现类似的反常降低。通过核糖核酸酶保护试验定量的肝脏REPR mRNA在喂食胆固醇的大鼠中降低了25-50%。用REPR补充剂可将从喂食胆固醇的甲状腺功能减退大鼠制备的肝脏S-100提取物的编辑活性恢复到对照水平,但用鸡肠道S-100提取物则不能,这表明REPR而非互补活性的变化可能在大鼠肝脏apoB mRNA编辑的调节中起关键作用。相比之下,用REPR补充剂对从甲状腺功能亢进动物制备的肠道S-100提取物的编辑活性没有影响,但在添加鸡肠道S-100提取物后恢复到对照水平。综上所述,数据表明组织特异性因子调节大鼠中的apoB mRNA编辑,并且REPR与互补因子之间的复杂相互作用可能会因体内胆固醇通量的改变而受到调节。